ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG) for BOEING COMPANY
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 22, 2024 | $50,000 | Replaced |
| 4th Quarter - Termination (this page) | Apr 15, 2024 | $50,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
- HR 3561, Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 (the PATIENT Act) - HR 4507, Transparency in Coverage Act - HR 4822, Health Care Price Transparency Act - HR 5378, Lower Costs, More Transparency Act - HR 5688, Bipartisan HSA Improvement Act - General health care and employee benefits issues: Health care coverage; regulatory implementation; transparency, delivery and payment reform; cost containment and telehealth; proposals related to ERISA preemption - H.R. 1843, S. 1001 - Telehealth Expansion Act of 2023 - H.R. 824 - the Telehealth Benefit Expansion for Workers Act of 2023 - S. 628, H.R. 3029 - the Primary Care Enhancement Act of 2023 - S. 1339 - Pharmacy Benefit Manager Reform Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| TARA BRADSHAW | — |
| HEATHER MEADE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.